CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes EVP, CFO gave up 37,178 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 50,539 shares (to pay taxes)
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 26,586 shares (grant or award)
- 4 Grant or award Director acquired 26,586 shares (grant or award)
- 4 Grant or award Director acquired 26,586 shares (grant or award)
- 4 Grant or award Director acquired 26,586 shares (grant or award)
- 4 Grant or award EVP, CFO acquired 137,500 shares (grant or award)
- 4 Grant or award Director acquired 26,586 shares (grant or award)
- 4 Grant or award President and CEO acquired 300,000 shares (grant or award)
- 4 Grant or award Director acquired 26,586 shares (grant or award)
- 8-K Event Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Other events
Page 16 of 50 · 1,000 filings